Verrica Pharmaceuticals Inc.
VRCA • NASDAQ
Verrica Pharmaceuticals Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jayson Rieger, with a market cap of $100.2M.
Market Cap$100.2M
Employees100.0
CEOJayson Rieger
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Verrica Pharmaceuticals Inc. FAQ
Common questions about Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $4.6M.
Verrica Pharmaceuticals Inc. has approximately 100 employees.